tradingkey.logo

Bio Rad Laboratories Inc

BIOb
300.500USD
-4.970-1.63%
收盘 12/19, 16:00美东报价延迟15分钟
8.11B总市值
亏损市盈率 TTM

Bio Rad Laboratories Inc

300.500
-4.970-1.63%

关于 Bio Rad Laboratories Inc 公司

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Bio Rad Laboratories Inc简介

公司代码BIOb
公司名称Bio Rad Laboratories Inc
上市日期Mar 17, 1980
CEOSchwartz (Norman D)
员工数量7700
证券类型Ordinary Share
年结日Mar 17
公司地址1000 Alfred Nobel Dr
城市HERCULES
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编94547
电话15107247000
网址https://www.bio-rad.com/
公司代码BIOb
上市日期Mar 17, 1980
CEOSchwartz (Norman D)

Bio Rad Laboratories Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
431.47K
+15.22%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
--
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Mr. Roop K. Lakkaraju
Mr. Roop K. Lakkaraju
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
--
--
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
--
--
Mr. Edward Chung
Mr. Edward Chung
Vice President - Investor Relations
Vice President - Investor Relations
--
--
Mr. James J. Barry
Mr. James J. Barry
Executive Vice President, President - Life Science Group
Executive Vice President, President - Life Science Group
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
431.47K
+15.22%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
--
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Mr. Roop K. Lakkaraju
Mr. Roop K. Lakkaraju
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
266.90M
40.96%
Europe
217.20M
33.33%
APAC
126.40M
19.40%
Other
41.10M
6.31%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 4月2日 周三
更新时间: 4月2日 周三
持股股东
股东类型
持股股东
持股股东
占比
Blue Raven Partners, L.P.
80.10%
Alice N. Schwartz Revocable Trust
8.63%
Schwartz (Norman D)
8.51%
Schwartz (Steven D)
0.75%
Allison (Schwartz)
0.08%
其他
1.92%
持股股东
持股股东
占比
Blue Raven Partners, L.P.
80.10%
Alice N. Schwartz Revocable Trust
8.63%
Schwartz (Norman D)
8.51%
Schwartz (Steven D)
0.75%
Allison (Schwartz)
0.08%
其他
1.92%
股东类型
持股股东
占比
Corporation
88.74%
Individual Investor
9.35%
Investment Advisor
0.07%
其他
1.85%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
13
3.80K
0.06%
--
2025Q3
15
3.80K
0.10%
+757.00
2025Q2
15
3.05K
0.12%
+2.00
2025Q1
18
3.04K
0.13%
-3.56K
2024Q4
18
4.22K
0.13%
-23.00
2024Q3
17
4.24K
0.12%
+647.00
2024Q2
18
3.60K
0.13%
-211.00
2024Q1
19
3.81K
0.15%
-3.64K
2023Q4
20
3.78K
2.06%
-1.99K
2023Q3
20
5.76K
2.06%
+2.00
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Blue Raven Partners, L.P.
4.06M
80.08%
--
--
May 01, 2025
Alice N. Schwartz Revocable Trust
437.51K
8.63%
--
--
May 01, 2025
Schwartz (Norman D)
374.47K
7.39%
+114.00
+0.03%
Feb 24, 2025
Schwartz (Steven D)
38.24K
0.75%
+57.00
+0.15%
Feb 24, 2025
Allison (Schwartz)
4.00K
0.08%
+57.00
+1.45%
Feb 24, 2025
CSS, LLC
1.09K
0.02%
--
--
Jun 30, 2025
Focus Partners Wealth, LLC
--
0%
-760.00
-100.00%
Mar 31, 2025
Buckingham Strategic Wealth, LLC
760.00
0.01%
--
--
Jun 30, 2024
Morgan Stanley Smith Barney LLC
692.00
0.01%
--
--
Jun 30, 2025
Wells Fargo Advisors
170.00
0%
--
--
Jun 30, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Bio Rad Laboratories Inc的前五大股东是谁?

Bio Rad Laboratories Inc 的前五大股东如下:
Blue Raven Partners, L.P.持有股份:4.06M,占总股份比例:80.08%。
Alice N. Schwartz Revocable Trust持有股份:437.51K,占总股份比例:8.63%。
Schwartz (Norman D)持有股份:374.47K,占总股份比例:7.39%。
Schwartz (Steven D)持有股份:38.24K,占总股份比例:0.75%。
Allison (Schwartz)持有股份:4.00K,占总股份比例:0.08%。

Bio Rad Laboratories Inc的前三大股东类型是什么?

Bio Rad Laboratories Inc 的前三大股东类型分别是:
Blue Raven Partners, L.P.
Alice N. Schwartz Revocable Trust
Schwartz (Norman D)

有多少机构持有Bio Rad Laboratories Inc(BIOb)的股份?

截至2025Q4,共有13家机构持有Bio Rad Laboratories Inc的股份,合计持有的股份价值约为3.80K,占公司总股份的0.06%。与2025Q3相比,机构持股有所增加,增幅为-0.04%。

哪个业务部门对Bio Rad Laboratories Inc的收入贡献最大?

在FY2025Q2,--业务部门对Bio Rad Laboratories Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI